Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PI103 | 0.1 | uM | 1 | GRO-a | 5702.0 | 58 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 19758.5 | 56 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 19872.0 | 60 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 20361.0 | 51 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 19884.0 | 72 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 19519.5 | 64 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 18177.0 | 53 | |
N2586 | PI103 | 0.1 | uM | 1 | GRO-a | 6616.0 | 47 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | GRO-a | 3304.0 | 72 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 2067.0 | 66 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 2404.0 | 63 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 4025.0 | 66 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 3999.5 | 50 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 2723.0 | 67 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | GRO-a | 5086.0 | 56 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | GRO-a | 9237.0 | 46 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 6270.0 | 55 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 5139.0 | 44 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 7502.0 | 52 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 7116.0 | 49 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | GRO-a | 5852.0 | 54 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | GRO-a | 10293.5 | 64 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | GRO-a | 11825.0 | 61 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | GRO-a | 7062.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | GRO-a | 15310.5 | 50 |